TY - JOUR
KW - Administration, Oral
KW - Adult
KW - Adverse events
KW - Anhedonia
KW - Anhedonia/drug effects
KW - Anxiety/chemically induced/epidemiology/psychology
KW - Depression/chemically induced/epidemiology/psychology
KW - Female
KW - Heroin
KW - Humans
KW - Male
KW - Naltrexone
KW - Naltrexone/administration & dosage/adverse effects
KW - Narcotic Antagonists/administration & dosage/adverse effects
KW - Opioid-Related Disorders/drug therapy/epidemiology/psychology
KW - Opioids
KW - Patient Dropouts/psychology
KW - Retention
KW - Treatment Outcome
AU - K. M. Carroll
AU - C. Nich
AU - T. L. Frankforter
AU - S. W. Yip
AU - B. D. Kiluk
AU - E. E. DeVito
AU - M. Sofuoglu
A1 - 
BT - Drug and alcohol dependence
C5 - Medically Unexplained Symptoms; Opioids & Substance Use
CY - Ireland
JF - Drug and alcohol dependence
PB - Elsevier B.V
PP - Ireland
PY - 2018
SN - 1879-0046; 0376-8716
SP - 264
EP - 270
EP - 
T1 - Accounting for the uncounted: Physical and affective distress in individuals dropping out of oral naltrexone treatment for opioid use disorder
T2 - Drug and alcohol dependence
TI - Accounting for the uncounted: Physical and affective distress in individuals dropping out of oral naltrexone treatment for opioid use disorder
U1 - Medically Unexplained Symptoms; Opioids & Substance Use
U2 - 30300800
VL - 192
VO - 1879-0046; 0376-8716
Y1 - 2018
ER -